MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma

Table 3

Univariate and multivariate analyses of clinical prognostic parameters in the CGGA dataset. MXRA5 expression was an independent prognostic factor in the CGGA dataset.

Variable	Univariate analysis		Multivariate analysis
	HR (95% CI)	value	HR (95% CI)	value
MXRA5 expression	2.310 (1.717-3.107)	<0.001	1.491 (1.071-2.077)	0.018
		Age at diagnosis		2.079 (1.555-2.779)	<0.001	1.376 (1.011-1.873)	0.042
WHO grade	4.552 (3.356-6.176)		<0.001		3.402 (2.382-4.857)		<0.001
		IDH mutation	2.524 (1.859-3.426)	<0.001		1.212 (0.832-1.765)	0.317